David Toung
Stock Analyst at Argus Research
(3.27)
# 1,027
Out of 5,241 analysts
133
Total ratings
61.17%
Success rate
9.24%
Average return
Main Sectors:
Stocks Rated by David Toung
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Upgrades: Buy | $400 | $393.85 | +1.56% | 9 | Apr 22, 2026 | |
| IART Integra LifeSciences Holdings | Downgrades: Hold | n/a | $14.10 | - | 3 | Apr 15, 2026 | |
| MDT Medtronic | Maintains: Buy | $125 → $115 | $76.15 | +51.02% | 8 | Apr 6, 2026 | |
| BDX Becton, Dickinson and Company | Maintains: Buy | $230 → $180 | $143.47 | +25.46% | 1 | Mar 23, 2026 | |
| PFE Pfizer | Upgrades: Buy | $35 | $25.33 | +38.18% | 2 | Mar 2, 2026 | |
| HCA HCA Healthcare | Maintains: Buy | $530 → $560 | $423.00 | +32.39% | 3 | Feb 6, 2026 | |
| TECH Bio-Techne | Maintains: Buy | $65 → $68 | $43.30 | +57.04% | 4 | Nov 20, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $580 → $610 | $438.34 | +39.16% | 8 | Oct 29, 2025 | |
| HUM Humana | Reiterates: Hold | $282 | $305.12 | -7.58% | 9 | Aug 14, 2025 | |
| ELV Elevance Health | Downgrades: Hold | n/a | $392.68 | - | 4 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $71.03 | -26.79% | 1 | Jul 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $210.39 | - | 6 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $115 → $125 | $195.20 | -35.96% | 9 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $150.85 | - | 5 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $300 → $340 | $326.31 | +4.20% | 10 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $570 → $670 | $760.57 | -11.91% | 6 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $150 | $83.70 | +79.21% | 7 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $770 → $840 | $1,004.92 | -16.41% | 3 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $60.76 | +81.04% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $250.40 | - | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $285 → $310 | $306.76 | +1.06% | 2 | May 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $265 → $320 | $421.12 | -24.01% | 3 | Dec 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $135 | $84.47 | +59.82% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $75 | $129.58 | -42.12% | 5 | Jan 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $57.00 | - | 4 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $110 | $111.38 | -1.24% | 3 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $6.36 | - | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $181.58 | - | 4 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $148.08 | - | 3 | Mar 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $165 → $155 | $226.71 | -31.63% | 4 | Mar 27, 2020 |
UnitedHealth Group
Apr 22, 2026
Upgrades: Buy
Price Target: $400
Current: $393.85
Upside: +1.56%
Integra LifeSciences Holdings
Apr 15, 2026
Downgrades: Hold
Price Target: n/a
Current: $14.10
Upside: -
Medtronic
Apr 6, 2026
Maintains: Buy
Price Target: $125 → $115
Current: $76.15
Upside: +51.02%
Becton, Dickinson and Company
Mar 23, 2026
Maintains: Buy
Price Target: $230 → $180
Current: $143.47
Upside: +25.46%
Pfizer
Mar 2, 2026
Upgrades: Buy
Price Target: $35
Current: $25.33
Upside: +38.18%
HCA Healthcare
Feb 6, 2026
Maintains: Buy
Price Target: $530 → $560
Current: $423.00
Upside: +32.39%
Bio-Techne
Nov 20, 2025
Maintains: Buy
Price Target: $65 → $68
Current: $43.30
Upside: +57.04%
Thermo Fisher Scientific
Oct 29, 2025
Maintains: Buy
Price Target: $580 → $610
Current: $438.34
Upside: +39.16%
Humana
Aug 14, 2025
Reiterates: Hold
Price Target: $282
Current: $305.12
Upside: -7.58%
Elevance Health
Jul 21, 2025
Downgrades: Hold
Price Target: n/a
Current: $392.68
Upside: -
Jul 1, 2025
Initiates: Buy
Price Target: $52
Current: $71.03
Upside: -26.79%
Nov 4, 2024
Upgrades: Buy
Price Target: n/a
Current: $210.39
Upside: -
Sep 11, 2024
Maintains: Buy
Price Target: $115 → $125
Current: $195.20
Upside: -35.96%
Jun 28, 2024
Downgrades: Hold
Price Target: n/a
Current: $150.85
Upside: -
Jun 27, 2024
Maintains: Buy
Price Target: $300 → $340
Current: $326.31
Upside: +4.20%
Jun 24, 2024
Maintains: Buy
Price Target: $570 → $670
Current: $760.57
Upside: -11.91%
May 21, 2024
Upgrades: Buy
Price Target: $150
Current: $83.70
Upside: +79.21%
May 14, 2024
Maintains: Buy
Price Target: $770 → $840
Current: $1,004.92
Upside: -16.41%
Apr 1, 2024
Maintains: Buy
Price Target: $80 → $110
Current: $60.76
Upside: +81.04%
Mar 25, 2024
Upgrades: Buy
Price Target: n/a
Current: $250.40
Upside: -
May 25, 2023
Maintains: Buy
Price Target: $285 → $310
Current: $306.76
Upside: +1.06%
Dec 22, 2022
Maintains: Buy
Price Target: $265 → $320
Current: $421.12
Upside: -24.01%
Jul 28, 2022
Maintains: Buy
Price Target: $150 → $135
Current: $84.47
Upside: +59.82%
Jan 28, 2022
Upgrades: Buy
Price Target: $75
Current: $129.58
Upside: -42.12%
Nov 1, 2021
Downgrades: Hold
Price Target: n/a
Current: $57.00
Upside: -
Nov 1, 2021
Upgrades: Buy
Price Target: $110
Current: $111.38
Upside: -1.24%
Aug 2, 2021
Downgrades: Hold
Price Target: n/a
Current: $6.36
Upside: -
Apr 12, 2021
Downgrades: Hold
Price Target: n/a
Current: $181.58
Upside: -
Mar 10, 2021
Downgrades: Hold
Price Target: n/a
Current: $148.08
Upside: -
Mar 27, 2020
Reiterates: Buy
Price Target: $165 → $155
Current: $226.71
Upside: -31.63%